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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is an important cause of both healthcare-associated MRSA (HA-MRSA) and
community-associated MRSA (CA-MRSA) infections. Severe MRSA infections have been associated with the virulence factor Panton–
Valentine leukocidin (PVL). The aim of this study was to investigate susceptibility patterns, the presence of toxin genes, including that
encoding PVL, and clonality among MRSA isolates collected from patients in Greece over a 12-year period. MRSA isolates were collected
from January 2001 to December 2012 from six different hospitals. Antibiotic susceptibility was determined with the disk diffusion method
and the Etest. The presence of the toxic shock syndrome toxin-1 gene (tst), the enterotoxin gene cluster (egc) and the PVL gene was tested
with PCR. The genotypic characteristics of the strains were analysed by SCCmec and agr typing, and clonality was determined with
pulsed-ﬁeld gel electrophoresis and multilocus sequence typing. An increasing rate of MRSA among S. aureus infections was detected up to
2008. The majority of PVL-positive MRSA isolates belonged to a single clone, sequence type (ST)80-IV, which was disseminated both in the
community and in hospitals, especially during the warmest months of the year. Carriage of tst was associated with ST30-IV, whereas egc was
distributed in different clones. CA-MRSA isolates were recovered mainly from skin and soft tissue infections, whereas HA-MRSA isolates
were associated with surgical and wound infections. During the period 2001–2012, ST80-IV predominated in the community and inﬁltrated
the hospital settings in Greece, successfully replacing other PVL-positive clones. The predominance of ST239-III in HA-MRSA infections was
constant, whereas new clones have also emerged. Polyclonality was statistically signiﬁcantly higher among CA-MRSA isolates and isolates
from adult patients.
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Abstract
Patients newly admitted to rehabilitation centres are at high risk of colonization with multidrug-resistant bacteria because many of them
have experienced prolonged stays in other healthcare settings and have had high exposure to antibiotics. We conducted a prospective study
to determine the prevalence of and risk factors for colonization with extended-spectrum beta-lactamase-producing Enterobacteriaceae
(ESBL-PE) in this population. Subjects were screened by rectal swab for ESBL-PE within 2 days of admission. Swabs were plated on
chromagar ESBL plates and the presence of ESBL was veriﬁed by a central laboratory. A multilevel mixed effects model was used to identify
risk factors for ESBL-PE colonization. Of 2873 patients screened, 748 (26.0%) were positive for ESBL-PE. The variables identiﬁed as
independently associated with ESBL-PE colonization were: recent stay in an acute-care hospital for over 2 weeks (OR = 1.34; 95% CI, 1.12,
1.6), history of colonization with ESBL-PE (OR = 2.97; 95% CI, 1.99, 4.43), unconsciousness on admission (OR = 2.59; 95% CI, 1.55, 4.34),
surgery or invasive procedure in the past year (OR = 1.49; 95% CI, 1.2, 1.86) and antibiotic treatment in the past month (OR = 1.80; 95%
CI, 1.45, 2.22). The predictive accuracy of the model was low (area under the ROC curve 0.656). These results indicate that ESBL-PE
colonization is common upon admission to rehabilitation centres. Some risk factors for ESBL-PE colonization are similar to those described
previously; however, newly identiﬁed factors may be speciﬁc to rehabilitation populations. The high prevalence and low ability to stratify by
risk factors may guide infection control and empirical treatment strategies in rehabilitation settings.
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Abstract
b-lactamase production has been sporadically reported in the emerging Kingella kingae pathogen but the phenomenon has not been studied
in-depth. We investigated the prevalence of b-lactamase production among K. kingae isolates from different geographical origins and
genetically characterized b-lactamase-producing strains. Seven hundred and seventy-eight isolates from Iceland, the USA, France, Israel,
Spain and Canada were screened for b-lactamase production and, if positive, were characterized by PFGE and MLST genotyping, as well as
rtxA, por, blaTEM and 16S rRNA sequencing. b-lactamase was identiﬁed in invasive strains from Iceland (n = 4/14, 28.6%), the USA (n = 3/15,
20.0%) and Israel (n = 2/190, 1.1%) and in carriage strains in the USA (n = 5/17, 29.4%) and Israel (n = 66/429, 15.4%). No French, Spanish
or Canadian isolates were b-lactamase producers. Among b-lactamase producers, a perfect congruency between the different typing
methods was observed. Surprisingly, all US and Icelandic b-lactamase-producing isolates were almost indistinguishable, belonged to the
major international invasive PFGE clone K/MLST ST-6, but differed from the four genetically unrelated Israeli b-lactamase-producing clones.
Representative strains of different genotypes produced the TEM-1 enzyme. K. kingae b-lactamase producers exhibit a clear clonal
distribution and have dissimilar invasive potential. The presence of the enzyme in isolates belonging to the major worldwide invasive clone
K/ST-6 highlights the possible spread of b-lactam resistance, and emphasizes the importance of routine testing of all K. kingae clinical isolates
for b-lactamase production.
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Abstract
The molecular epidemiology and prevalence of virulence factors of isolates from patients with Klebsiella pneumoniae liver abscess (KLA) in
mainland China are unknown. Klebsiella pneumoniae isolates were obtained from drainage samples aseptically collected from patients with
pyogenic liver abscess (PLA). The genetic similarity of KLA isolates was analyzed by pulsed-ﬁeld gel electrophoresis. The hypermucoviscosity
(HV) phenotype was identiﬁed by a positive string test. The K1 and K2 genotypes, the pLVPK-derived genetic loci, aerobactin gene, kfu and
alls were detected by PCR ampliﬁcation. The sequence types (STs) were identiﬁed by multilocus sequence typing. Among the 51
non-repetitive KLA isolates, 49 PFGE types have been identiﬁed. In total, 19 (37.2%) and 14 (27.4%) of the 51 KLA isolates belonged to
clonal complex (CC) 23 and CC65, respectively, while the other 18 isolates (35.3%) were deﬁned as other STs. CC23 consisted of only K1
strains, while CC65 included only K2 strains. All non-K1/K2 strains were classiﬁed as STs other than CC23 and CC65. Approximately 70.6%
(36/51) of KLA isolates exhibited an HV phenotype. Both K1 and K2 isolates presented signiﬁcantly higher prevalence of the pLVPK-derived
loci than non-K1/K2 isolates. The K1 isolates had a signiﬁcantly higher prevalence of the kfu and allS genes than K2 and non-K1/K2 isolates,
while the K2 isolates exhibited higher repA prevalence than K1 and non-K1/K2 isolates. The majority of KLA isolates belonged to CC23K1
and CC65K2, while other STs with non-K1/K2 capsular types have also been identiﬁed. The virulent factors exhibited diverse distribution
among the different clones of KLA isolates.
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Abstract
Resistance of Bordetella pertussis, the causative agent of pertussis, to erythromycin is rare. Recently, several Chinese isolates were found to
be erythromycin resistant. This study aimed to investigate the occurrence of pertussis in children suffering persistent cough and the
prevalence of B. pertussis resistance to erythromycin in Xi’an, China. Three hundred and thirteen patients with suspected pertussis admitted
to Xi’an Children’s Hospital from January 2012 through to December 2013 were included and their nasopharyngeal (NP) swabs were taken
for culture and PCRs (targeting IS481 and ptx-Pr). PCR-based sequencing was used to identify the A2047G mutation of B. pertussis 23S
rRNA directly from the NP samples. Sixteen (5.1%) and 168 (53.7%) patients were positive for culture and IS481 PCR. Of the 168 samples
positive for IS481 PCR, 122 (72.6%) and 100 (59.5%) were positive for ptx-Pr and 23S rRNA PCRs, respectively. All culture-positive samples
were also positive for the three PCRs. Fourteen (87.5%) of the 16 B. pertussis isolates were found to be resistant to erythromycin
(MICs > 256 mg/L). All the 14 isolates were conﬁrmed to have a homogeneous A2047G mutation of 23S rRNA. Of the 100 samples
positive for 23S rRNA PCR, 85 (85.0%) were found to have the A2047G mutation by sequencing. Our results indicate that in Xi’an, China,
pertussis remains endemic in young children, and the circulating B. pertussis strains are mostly erythromycin resistant.
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Abstract
The inoculum effect is a laboratory phenomenon in which the minimal inhibitory concentration (MIC) of an antibiotic is increased when a
large number of organisms are exposed. Due to the emergence of extended-spectrum b-lactamase-producing Klebsiella pneumoniae
(ESBL-Kpn) infections, the inoculum effect of ESBL-Kpn on b-lactams was studied in vitro and in vivo using an experimental model of
pneumonia. The in vitro inoculum effect of 45 clinical ESBL-Kpn isolates on b-lactams was evaluated at standard (105 CFU/mL) and high
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(107 CFU/mL) organism concentrations. The MIC50 of piperacillin-tazobactam, cefotaxime and cefepime was increased eight-fold or more
and that of meropenem was increased two-fold. The in vivo inoculum effect was evaluated in an ESBL-Kpn pneumonia mouse model treated
with bacteriostatic effect-adjusted doses of piperacillin-tazobactam (1000 mg/kg four times daily, %T > MIC; 32.60%) or meropenem
(100 mg/kg twice daily, %T > MIC; 28.65%) at low/standard (104 CFU/mouse) and high (106 CFU/mouse) inocula. In mice administered a
low inoculum, no mice died after treatment with piperacillin-tazobactam or meropenem, whereas all the control mice died. In contrast, in
the high inoculum model, all mice in the piperacillin-tazobactam-treated group died, whereas all meropenem-treated mice survived and had
a decreased bacterial load in the lungs and no invasion into the blood. In conclusion, meropenem was more resistant to the inoculum effect
of ESBL-Kpn than piperacillin-tazobactam both in vitro and in vivo. In the management of severe pneumonia caused by ESBL-Kpn,
carbapenems may be the drugs of choice to achieve a successful outcome.
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Abstract
Panton-Valentine leukocidin (PVL) is the hallmark of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) but can also
be found in methicillin-susceptible S. aureus (MSSA) sharing pathogenic and epidemiological characteristics of CA-MRSA. PVL is encoded by
two co-transcribed genes that are carried by different staphylococcal bacteriophages. We applied an extended PCR-based typing scheme for
the identiﬁcation of two morphological groups (elongated-head group and icosahedral-head group I phages) and speciﬁc PVL phage types in
S. aureus isolates recovered in Italy. We examined 48 PVL-positive isolates (25 MSSA and 23 MRSA) collected from different hospital
laboratories from April 2005 to May 2011. spa typing, multilocus sequence typing and staphylococcal cassette chromosome mec typing were
applied to categorize the isolates. Phage typeability was 48.0% in MSSA and 91.3% in MRSA, highlighting the limitation of the PCR typing
scheme when applied to PVL-positive MSSA. Five different PVL phages and two variants of a known phage were detected, the most
prevalent being ΦSa2usa, recovered in 15 out of 48 (31.2%) isolates, and carried by both MSSA and MRSA belonging to CC8 and CC5. The
recently described ΦTCH60 was recovered in four isolates. A PVL phage (ΦSa119) from an ST772 MRSA, that was not detected using the
previous typing scheme, was sequenced, and new primers were designed for the identiﬁcation of the icosahedral-head group II PVL phages
present in ST772 and ST59 MRSA. A comprehensive PVL-phage typing can contribute to the understanding of the epidemiology and
evolution of PVL-positive MSSA and MRSA.
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Abstract
This study reviewed the clinical, laboratory, therapeutic and prognostic data on genitourinary involvement of brucellosis in this largest case
series reported. This multicentre study pooled adult patients with genitourinary brucellar involvement from 34 centres treated between
2000 and 2013. Diagnosis of the disease was established by conventional methods. Overall 390 patients with genitourinary brucellosis (352
male, 90.2%) were pooled. In male patients, the most frequent involved site was the scrotal area (n = 327, 83.8%), as epididymo-orchitis
(n = 204, 58%), orchitis (n = 112, 31.8%) and epididymitis (n = 11, 3.1%). In female patients, pyelonephritis (n = 33/38, 86.8%) was
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signiﬁcantly higher than in male patients (n = 11/352, 3.1%; p< 0.0001). The mean blood leukocyte count was 7530  3115/mm3. Routine
laboratory analysis revealed mild to moderate increases for erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). The mean
treatment duration and length of hospital stay were signiﬁcantly higher when there were additional brucellar foci (p< 0.05). Surgical
operations including orchiectomy and abscess drainage were performed in nine (2.3%) patients. Therapeutic failure was detected in six
(1.5%), relapse occurred in four (1%), and persistent infertility related to brucellosis occurred in one patient. A localized scrotal infection in
men or pyelonephritis in women in the absence of leucocytosis and with mild to moderate increases in inﬂammatory markers should signal
the possibility of brucellar genitourinary disease.
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